about
Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combinationRationally designed, nontoxic, nonamyloidogenic analogues of human islet amyloid polypeptide with improved solubilityUpdate in the pharmacologic treatment of diabetes mellitus: focus on pramlintide and exenatide.Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.History of current non-insulin medications for diabetes mellitus.Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk.Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus.
P2860
Q27026211-35697609-8B84-4582-A5B8-F06B752FAEBCQ34230460-E527945B-E3BF-4D4B-B1C8-D0334355E0A4Q36593147-152BE295-0516-437E-85BA-1166DF2F048EQ36634230-7ABFA76E-2CD2-4B3F-A258-9C0BD4DAF484Q37021310-002113FD-4786-4520-91F0-B21156B8C3D0Q37193917-844A42E4-4203-4039-ADDD-F9C11BBC0F2AQ46207930-29316B63-8841-4073-ABD5-509DAA2CDC23
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pramlintide for the treatment of diabetes mellitus.
@ast
Pramlintide for the treatment of diabetes mellitus.
@en
type
label
Pramlintide for the treatment of diabetes mellitus.
@ast
Pramlintide for the treatment of diabetes mellitus.
@en
prefLabel
Pramlintide for the treatment of diabetes mellitus.
@ast
Pramlintide for the treatment of diabetes mellitus.
@en
P2860
P356
P1476
Pramlintide for the treatment of diabetes mellitus.
@en
P2093
Erika L Kleppinger
Eva M Vivian
P2860
P304
P356
10.1345/APH.1C387
P407
P577
2003-07-01T00:00:00Z